{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:06Z","timestamp":1787027046054,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00479","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T23:32:00Z","timestamp":1573601520000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study"],"prefix":"10.3389","volume":"7","author":[{"given":"Luca","family":"Filippi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Perciasepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Araimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Regiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genny","family":"Raffaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dal Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Calvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pina","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Osnaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/archdischild-2016-310532","article-title":"Epidemiology of blindness in children","volume":"102","author":"Solebo","year":"2017","journal-title":"Arch Dis Child."},{"key":"B3","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41372-019-0357-2","article-title":"Prenatal and postnatal inflammation-related risk factors for retinopathy of prematurity","volume":"39","author":"Goldstein","year":"2019","journal-title":"J Perinatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e20153387","DOI":"10.1542\/peds.2015-3387","article-title":"Interventions to prevent retinopathy of prematurity: a meta-analysis","volume":"137","author":"Fang","year":"2016","journal-title":"Pediatrics."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"B6","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e186801","DOI":"10.1001\/jamanetworkopen.2018.6801","article-title":"Prevalence of severe visual disability among preterm children with retinopathy of prematurity and association with adherence to best practice guidelines","volume":"2","author":"Norman","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B8","doi-asserted-by":"publisher","first-page":"F179","DOI":"10.1136\/archdischild-2014-306207","article-title":"Impact of retinopathy of prematurity on ocular structures and visual functions","volume":"100","author":"Fielder","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3980\/j.issn.2222-3959.2013.02.23","article-title":"Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options","volume":"6","author":"Mutlu","year":"2013","journal-title":"Int J Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1097\/01.iae.0000244293.94251.20","article-title":"Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 years","volume":"26","author":"Hurley","year":"2006","journal-title":"Retina."},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD009734","DOI":"10.1002\/14651858.CD009734.pub3","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12886-018-0685-6","article-title":"Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)","volume":"18","author":"Li","year":"2018","journal-title":"BMC Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3892\/etm.2015.2650","article-title":"Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9","volume":"10","author":"Wu","year":"2015","journal-title":"Exp Ther Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/pbc.25453","article-title":"Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K\/Akt\/eNOS\/VEGF pathway","volume":"62","author":"Pan","year":"2015","journal-title":"Pediatr Blood Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/med.21336","article-title":"Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the \u03b2-adrenergic system","volume":"35","author":"Filippi","year":"2015","journal-title":"Med Res Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1167\/iovs.11-9408","article-title":"Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity","volume":"53","author":"Dal Monte","year":"2012","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1471-4159.2011.07530.x","article-title":"Antiangiogenic effects of \u03b22 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy","volume":"119","author":"Martini","year":"2011","journal-title":"J Neurochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fncel.2017.00395","article-title":"The beta adrenergic receptor blocker propranolol counteracts retinal dysfunction in a mouse model of oxygen induced retinopathy: restoring the balance between apoptosis and autophagy","volume":"11","author":"Cammalleri","year":"2017","journal-title":"Front Cell Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/archdischild-2013-303951","article-title":"Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study","volume":"98","author":"Makhoul","year":"2013","journal-title":"Arch Dis Child."},{"key":"B24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/jpm-2015-0357","article-title":"Oral propranolol in early stages of retinopathy of prematurity","volume":"44","author":"Bancalari","year":"2016","journal-title":"J Perinat Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/02713683.2016.1158272","article-title":"The efficacy of propranolol in retinopathy of prematurity and its correlation with the platelet mass index","volume":"42","author":"Korkmaz","year":"2017","journal-title":"Curr Eye Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","article-title":"Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice","volume":"111","author":"Dal Monte","year":"2013","journal-title":"Exp Eye Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/pr.2014.108","article-title":"Pharmacokinetics and local safety profile of propranolol eye drops in rabbits","volume":"76","author":"Padrini","year":"2014","journal-title":"Pediatr Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/pr.2016.230","article-title":"Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial","volume":"81","author":"Filippi","year":"2017","journal-title":"Pediatr Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fped.2019.00180","article-title":"Propranolol 0.2% eye micro-drops for retinopathy of prematurity: a prospective phase IIB study","volume":"7","author":"Filippi","year":"2019","journal-title":"Front Pediatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/02713683.2017.1390769","article-title":"Short-term refractive effects of propranolol hydrochloride prophylaxis on retinopathy of prematurity in very preterm newborns","volume":"43","author":"Korkmaz","year":"2018","journal-title":"Curr Eye Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/bmj.324.7347.1195","article-title":"Myopia","volume":"324","author":"Fredrick","year":"2002","journal-title":"BMJ."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e8565","DOI":"10.1097\/MD.0000000000008565","article-title":"Refractive state and optical compositions of preterm children with and without retinopathy of prematurity in the first 6 years of life","volume":"96","author":"Zhu","year":"2017","journal-title":"Medicine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/1346-8138.13324","article-title":"Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas","volume":"43","author":"Hu","year":"2016","journal-title":"J Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/archopht.123.10.1404","article-title":"Development of spherical equivalent refraction in prematurely born children during the first 10 years of life: a population-based study","volume":"123","author":"Holmstr\u00f6m","year":"2005","journal-title":"Arch Ophthalmol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1167\/iovs.10-5234","article-title":"Long-term evaluation of refractive status and optical components in eyes of children born prematurely","volume":"51","author":"Chen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1542\/peds.109.1.12","article-title":"Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity","volume":"109","author":"O'Connor","year":"2002","journal-title":"Pediatrics."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00479\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T23:32:03Z","timestamp":1573601523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00479\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":37,"alternative-id":["10.3389\/fped.2019.00479"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00479","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]},"article-number":"479"}}